Cargando…
CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer
BACKGROUND: Studies have confirmed that Caudal Type Homeobox 2 (CDX2) plays a tumor suppressor role in colorectal cancer (CRC) and as a prognostic and predictive marker for colorectal cancer. The epithelial to mesenchymal transition (EMT) is a transdifferentiation process, providing migratory and in...
Autores principales: | Wang, Yun-shuai, Kou, Yu, Zhu, Ren-tao, Han, Bao-wei, Li, Chao-hui, Wang, Huang-jian, Wu, Hui-bin, Xia, Tian-ming, Che, Xiang-ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582897/ https://www.ncbi.nlm.nih.gov/pubmed/36277982 http://dx.doi.org/10.1155/2022/9025668 |
Ejemplares similares
-
Relationships Between the Expressions of CDX1 and CDX2 mRNA and Clinicopathologic Features in Colorectal Cancers
por: Kim, Gwang Ha, et al.
Publicado: (2005) -
GDF15 promotes EMT and metastasis in colorectal cancer
por: Li, Chen, et al.
Publicado: (2015) -
Methylation of promoter region of CDX2 gene in colorectal cancer
por: Wang, Yunshuai, et al.
Publicado: (2016) -
Overlapping functions of Cdx1, Cdx2, and Cdx4 in the development of the amphibian Xenopus tropicalis
por: Faas, Laura, et al.
Publicado: (2009) -
Cdx1 and Cdx2 Exhibit Transcriptional Specificity in the Intestine
por: Grainger, Stephanie, et al.
Publicado: (2013)